Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway.

MLA

Chahal, Harvinder S., et al. “Somatostatin Analogs Modulate AIP in Somatotroph Adenomas: The Role of the ZAC1 Pathway.” The Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 8, Aug. 2012, pp. E1411–20. EBSCOhost, https://doi.org/10.1210/jc.2012-1111.

APA

Chahal, H. S., Trivellin, G., Leontiou, C. A., Alband, N., Fowkes, R. C., Tahir, A., Igreja, S. C., Chapple, J. P., Jordan, S., Lupp, A., Schulz, S., Ansorge, O., Karavitaki, N., Carlsen, E., Wass, J. A. H., Grossman, A. B., & Korbonits, M. (2012). Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway. The Journal of Clinical Endocrinology and Metabolism, 97(8), E1411–E1420. https://doi.org/10.1210/jc.2012-1111

Chicago

Chahal, Harvinder S, Giampaolo Trivellin, Chrysanthia A Leontiou, Neda Alband, Robert C Fowkes, Asil Tahir, Susana C Igreja, et al. 2012. “Somatostatin Analogs Modulate AIP in Somatotroph Adenomas: The Role of the ZAC1 Pathway.” The Journal of Clinical Endocrinology and Metabolism 97 (8): E1411–20. doi:10.1210/jc.2012-1111.